Eri Kanaoka

808 total citations
15 papers, 693 citations indexed

About

Eri Kanaoka is a scholar working on Molecular Biology, Immunology and Infectious Diseases. According to data from OpenAlex, Eri Kanaoka has authored 15 papers receiving a total of 693 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Immunology and 2 papers in Infectious Diseases. Recurrent topics in Eri Kanaoka's work include Lipid Membrane Structure and Behavior (5 papers), Immunotherapy and Immune Responses (3 papers) and Analytical Chemistry and Chromatography (2 papers). Eri Kanaoka is often cited by papers focused on Lipid Membrane Structure and Behavior (5 papers), Immunotherapy and Immune Responses (3 papers) and Analytical Chemistry and Chromatography (2 papers). Eri Kanaoka collaborates with scholars based in Japan, United States and United Kingdom. Eri Kanaoka's co-authors include Takayoshi Yoshikawa, Yoshitaka Nishihara, Kohsaku Kawakami, Kazuyoshi Masuda, Koichiro Hirano, Joseph W. Polli, Joan E. Humphreys, Paul Savina, Lindsey O. Webster and Grant T. Generaux and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Controlled Release and International Journal of Pharmaceutics.

In The Last Decade

Eri Kanaoka

15 papers receiving 657 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eri Kanaoka Japan	11	235	182	173	91	91	15	693
Manisha Ramaswamy Canada	19	145 0.6×	169 0.9×	331 1.9×	72 0.8×	304 3.3×	28	1.0k
G. V. Betageri United States	16	433 1.8×	68 0.4×	433 2.5×	92 1.0×	53 0.6×	31	1.1k
Jan Rosier Belgium	14	197 0.8×	141 0.8×	144 0.8×	34 0.4×	17 0.2×	30	664
Mario A. Quevedo Argentina	14	137 0.6×	109 0.6×	153 0.9×	132 1.5×	67 0.7×	39	519
Darren Moss United Kingdom	17	97 0.4×	324 1.8×	234 1.4×	73 0.8×	143 1.6×	30	904
Jay Dintaman United States	4	165 0.7×	114 0.6×	122 0.7×	39 0.4×	224 2.5×	7	549
Keizo Fukushima Japan	15	410 1.7×	85 0.5×	161 0.9×	17 0.2×	140 1.5×	52	862
Sateesh Khandavilli India	10	251 1.1×	54 0.3×	78 0.5×	50 0.5×	56 0.6×	13	510
M. A. Campanero Spain	21	238 1.0×	78 0.4×	246 1.4×	40 0.4×	79 0.9×	41	1.2k
Ashwini Madgulkar India	18	525 2.2×	53 0.3×	194 1.1×	117 1.3×	32 0.4×	54	997

Countries citing papers authored by Eri Kanaoka

Since Specialization

Citations

This map shows the geographic impact of Eri Kanaoka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eri Kanaoka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eri Kanaoka more than expected).

Fields of papers citing papers by Eri Kanaoka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eri Kanaoka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eri Kanaoka. The network helps show where Eri Kanaoka may publish in the future.

Co-authorship network of co-authors of Eri Kanaoka

This figure shows the co-authorship network connecting the top 25 collaborators of Eri Kanaoka. A scholar is included among the top collaborators of Eri Kanaoka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eri Kanaoka. Eri Kanaoka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Wagner, David S., et al.. (2014). The comparative disposition and metabolism of dolutegravir, a potent HIV-1 integrase inhibitor, in mice, rats, and monkeys. Xenobiotica. 45(1). 60–70. 22 indexed citations

Kuroda, Takayuki, Mitsuru Notoya, Masashi Ito, et al.. (2012). Renoprotective Action of a Matrix Metalloproteinase Inhibitor in Progressive Mesangioproliferative Nephritis. SHILAP Revista de lepidopterología. 2(1). 133–146. 1 indexed citations

Reese, Melinda J., Paul Savina, Grant T. Generaux, et al.. (2012). In Vitro Investigations into the Roles of Drug Transporters and Metabolizing Enzymes in the Disposition and Drug Interactions of Dolutegravir, a HIV Integrase Inhibitor. Drug Metabolism and Disposition. 41(2). 353–361. 212 indexed citations

Yoshikawa, Takayoshi, Kohsaku Kawakami, & Eri Kanaoka. (2008). Application of liposome technology for inhalation therapy. Drug Delivery System. 23(4). 460–466. 2 indexed citations

Okamura, Noboru, Shingo Sakamoto, Hiroshi Hasegawa, et al.. (2008). Role of Na+/L-carnitine Transporter (OCTN2) in Renal Handling of Pivaloylcarnitine and Valproylcarnitine Formed during Pivalic Acid-containing Prodrugs and Valproic Acid Treatment. Drug Metabolism and Pharmacokinetics. 23(4). 293–303. 21 indexed citations

Kanaoka, Eri, et al.. (2003). Continuous Release of Interleukin-2 from Liposomal IL-2 (Mixture of Interleukin-2 and Liposomes) After Subcutaneous Administration to Mice. Drug Development and Industrial Pharmacy. 29(10). 1149–1153. 11 indexed citations

Ishida, Yoichi, Eri Kanaoka, K. Takahashi, et al.. (2003). A new generic column switching system for quantitation in cassette dosing using LC/MS/MS. Journal of Pharmaceutical and Biomedical Analysis. 31(6). 1089–1099. 13 indexed citations

Kanaoka, Eri, Kouji Takahashi, Takayoshi Yoshikawa, et al.. (2002). A significant enhancement of therapeutic effect against hepatic metastases of M5076 in mice by a liposomal interleukin-2 (mixture). Journal of Controlled Release. 82(2-3). 183–187. 15 indexed citations

Kawakami, Kohsaku, et al.. (2002). Microemulsion formulation for enhanced absorption of poorly soluble drugs. Journal of Controlled Release. 81(1-2). 65–74. 269 indexed citations

10.

Kanaoka, Eri, et al.. (2001). A novel and simple type of liposome carrier for recombinant interleukin-2. Journal of Pharmacy and Pharmacology. 53(3). 295–302. 19 indexed citations

11.

Kanaoka, Eri, Shunji Nagata, & Koichiro Hirano. (1999). Stabilization of aerosolized IFN-γ by liposomes. International Journal of Pharmaceutics. 188(2). 165–172. 18 indexed citations

12.

Takahashi, Koji, et al.. (1997). Pharmacokinetics of interleukin-2 mixed with liposomes(Lipo-IL2) and its enhanced effect against hepatic metastases of M5076 reticulosarcoma in mice.. Drug Delivery System. 12(3). 181–186. 2 indexed citations

13.

Kanaoka, Eri, et al.. (1994). pH-Sensitive liposomes composed of tocopherol hemisuccinate and of phosphatidylethanolamine including tocopherol hemisuccinate. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1213(3). 343–348. 42 indexed citations

14.

Kanaoka, Eri, et al.. (1993). Gelatin-Acacia Microcapsules for Trapping Micro Oil Droplets Containing Lipophilic Drugs and Ready Disintegration in the Gastrointestinal Tract. Pharmaceutical Research. 10(8). 1115–1122. 39 indexed citations

15.

Kanaoka, Eri, et al.. (1989). Encapsulation of drugs by lyophilized, empty dipalmitoylphosphatidylcholine liposomes.. Chemical and Pharmaceutical Bulletin. 37(7). 1895–1898. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact